Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02112214 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population

Study acronym: HELPER
StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 3 versions Re-verified since Aug 31, 2021, no change to tracked fieldsv9-v11
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 11 of 11 sites
    v8
  3. Enrollment target: 11000 to 5224
    • Primary and study completion dates: Jun 2029 to Dec 2029
    • Collaborators: 10 to 11
    v7
  4. Primary and study completion dates: Dec 2027 to Jun 2029
    • Study sites: 6 to 11
    • Eligibility criteria revised
    • Collaborators revised (10)
    v6
  5. Collaborators: 9 to 10v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary and study completion dates: Dec 2026 to Dec 2027
    • Start date: Feb 2014 to Jun 2014
    • Interventions: 10-day bismuth-based quadruple therapy (Drug) to 10-day bismuth-based quadruple therapy (Drug), Placebo (Other)
    • Collaborators: 6 to 9
    v4
  2. Re-verified, no change to tracked fieldsv3
  3. Study sites revised (6)v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to define the role of H. pylori eradication in the prevention of gastric cancer and its precursors in the context of a population-based endoscopic screening program.
Trial Details
NCT Number NCT02112214
Lead Sponsor National Cancer Center, Korea
Collaborators: International Agency for Research on Cancer, Chonnam National University Hospital, Chung-Ang University Hospital, Pusan National University Hospital, Kyungpook National University Hospital, Uijeongbu St. Mary's Hospital/The Catholic University, Kangdong Sacred Heart Hospital, Incheon St.Mary's Hospital/The Catholic University, SMG-SNU Boramae Medical Center, Chuncheon Sacred Heart Hospital, Kosin University Gospel Hospital
Conditions
(from sponsor)		 Gastric Cancer, Helicobacter Pylori Infection
Related terms Stomach Neoplasms
Enrollment 5,224 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov